Patients' and nurses' preferences for autoinjectors for rheumatoid arthritis: results of a European survey

Patients' and nurses' preferences for autoinjectors for rheumatoid arthritis: results of a European survey

Bernd Tischer,1 Andrea Mehl2 1Kantar Health GmbH, Munich, Germany; 2Sandoz International GmbH, Holzkirchen, Germany Purpose: This survey investigated patients’ and nurses’ preferences among four different autoinjectors used for subcutaneous delivery of medication for rheumatoid...

Full description

Bibliographic Details
Main Authors:	Tischer B, Mehl A
Format:	Article
Language:	English
Published:	Dove Medical Press 2018-08-01
Series:	Patient Preference and Adherence
Subjects:	SensoReady® Erelzi® pen easy grip convenience autoinjection device test etanercept biosimilar
Online Access:	https://www.dovepress.com/patients-and-nurses-preferences-for-autoinjectors-for-rheumatoid-arthr-peer-reviewed-article-PPA

Similar Items

Comparison of the Pharmacokinetics, Safety, and Tolerability of the Autoinjector (AI) and Pre-Filled Syringe (PFS) of SB4 in Healthy Subjects
by: Shin D, et al.
Published: (2020-01-01)

Equivalence and switching between biosimilars and reference molecules in rheumatoid arthritis: protocol for a systematic review and meta-analysis
by: Bruna O. Ascef, et al.
Published: (2021-07-01)

Observational study of inflammatory arthritis treatment by etanercept originator switched to an etanercept biosimilar
by: Anna Felis-Giemza, et al.
Published: (2019-10-01)

Evaluation of the cost saving potential of introducing Benepali® and Flixabi® on the European and Italian markets
by: Cristina Negrini, et al.
Published: (2017-10-01)

Long-term efficacy, safety and immunogenicity in patients with rheumatoid arthritis continuing on an etanercept biosimilar (LBEC0101) or switching from reference etanercept to LBEC0101: an open-label extension of a phase III multicentre, randomised, double-blind, parallel-group study
by: Min-Chan Park, et al.
Published: (2019-05-01)

Switching patients with inflammatory arthritis from Etanercept (Enbrel®) to the biosimilar drug, SB4 (Benepali®): A single-centre retrospective observational study in the UK and a review of the literature
by: Madenidou Anastasia-Vasiliki, et al.
Published: (2019-01-01)

Duration of hydrothermal treatment and peeling of 'Murcott' tangor
by: Ana Luiza Pinheiro, et al.
Published: (2011-12-01)

Comparison of drug delivery with autoinjector versus manual prefilled syringe and between three different autoinjector devices administered in pig thigh
by: Hill RL, et al.
Published: (2016-08-01)

Switch from reference etanercept to SDZ ETN, an etanercept biosimilar, does not impact efficacy, safety, and immunogenicity of etanercept in patients with moderate-to-severe rheumatoid arthritis: 48-week results from the phase III, randomized, double-blind EQUIRA study
by: Janusz Jaworski, et al.
Published: (2019-05-01)

Clinical experience with two etanercept biosimilars in Indian patients with spondyloarthritis
by: Ashok Kumar, et al.
Published: (2017-01-01)

Learnings from Regional Market Dynamics of Originator and Biosimilar Infliximab and Etanercept in Germany
by: Evelien Moorkens, et al.
Published: (2020-10-01)

Enhancement of an Auto-Injector Device for Self-Administration of Etanercept in Patients With Rheumatoid Arthritis Confers Emotional and Functional Benefits
by: Naceur Rekaya, et al.
Published: (2020-06-01)

Nurse and Patient Perceptions and Preferences for Subcutaneous Autoinjectors for Inflammatory Joint or Bowel Disease: Findings from a European Survey
by: Steve Fenwick, et al.
Published: (2019-02-01)

Full dose, half dose, or discontinuation of etanercept biosimilar in early axial spondyloarthritis patients: a real-world study in China
by: Kun-Peng Li, et al.
Published: (2018-06-01)

Etanercept biosimilar associated with Guillain-Barré syndrome: insights from a case
by: V. Shobha, et al.
Published: (2019-07-01)

Current and Emerging DMARDs for the Treatment of Rheumatoid Arthritis
by: Mysler E, et al.
Published: (2021-06-01)

Etanercept In the treatment of AA-amyloidosis in juvenile rheumatoid arthritis
by: H Mihels
Published: (2004-08-01)

PENELOPE/PRIMO-calculated photon and electron spectra from clinical accelerators
by: Lorenzo Brualla, et al.
Published: (2019-01-01)

Etanercept in the treatment of Graves’ ophthalmopathy with primary hypothyroidism and rheumatoid arthritis
by: Olivera Boskovic, et al.
Published: (2020-01-01)

Predictors of Response to (Etanercept) in the Treatment of Iraqi Patients with Active Rheumatoid Arthritis
by: Nizar A. Jassim
Published: (2015-04-01)

Ten years' clinical experience with biosimilar human growth hormone: a review of efficacy data
by: López-Siguero JP, et al.
Published: (2017-05-01)

Effectiveness of Combination of Leflunomide and Methotrexate compared to Etanercept in the Treatment of Rheumatoid Arthritis: A systematic review and meta-analysis
by: Rashin Iman, et al.
Published: (2021-07-01)

Patients’ Perceptions and Preferences Regarding Two Different Forms of Methotrexate Autoinjectors for Moderate to Severe Rheumatoid Arthritis: A European Crossover Survey
by: Zeitoun JD, et al.
Published: (2020-11-01)

Microneedle-Assisted Transdermal Delivery of Etanercept for Rheumatoid Arthritis Treatment
by: Jian Cao, et al.
Published: (2019-05-01)

Structural and In Vitro Functional Comparability Analysis of Altebrel™, a Proposed Etanercept Biosimilar: Focus on Primary Sequence and Glycosylation
by: Ramin Fazel, et al.
Published: (2019-01-01)

Effectiveness of Subcutaneous Tumor Necrosis Factor Inhibitors in Patients With Ankylosing Spondylitis: A Real-World Prospective Observational Cohort Study in China
by: Xiaojian Ji, et al.
Published: (2019-12-01)

Treatment strategy for rheumatoid arthritis: hot topics
by: D. E. Karateev
Published: (2015-03-01)

Etanercept improved anemia and decreased hepcidin gene expression in a rat model of rheumatoid arthritis
by: Maha Safwat Elsheemy, et al.
Published: (2019-04-01)

A Comparative Study to Assess the Efficacy, Safety, and Immunogenicity of YLB113 and the Etanercept Reference Product for the Treatment of Patients with Rheumatoid Arthritis
by: Hisashi Yamanaka, et al.
Published: (2019-12-01)

Is drug discontinuation risk of adalimumab compared with etanercept affected by concomitant methotrexate dose in patients with rheumatoid arthritis?
by: Chen HH, et al.
Published: (2016-02-01)

Comparative Price Analysis of Biological Products for Treatment of Rheumatoid Arthritis
by: Manoela Manova, et al.
Published: (2018-09-01)

The results of investigating the efficacy and safety of non-medical switching from the original rituximab to its biosimilar in rheumatoid arthritis patients (AMBIRA study)
by: M. A. Korolev, et al.
Published: (2021-01-01)

Microbiological quality in convenient ready-to-eat vegetables during shelf life
by: Cátia Morgado, et al.
Published: (2018-10-01)

Psoriasis and Psoriatic Arthritis in ChildhoodPsoriasis and Psoriatic Arthritis in Childhood
by: Nikolay N. Murashkin, et al.
Published: (2020-12-01)

THE RESULTS OF A PHASE III COMPARATIVE CLINICAL TRIAL OF RITUXIMAB (ACELLBIA® AND MABTHERA®) IN RHEUMATOID ARTHRITIS (THE BIORA STUDY)
by: E. L. Nasonov, et al.
Published: (2016-12-01)

Assessing physician and patient acceptance of infliximab biosimilars in rheumatoid arthritis, ankylosing spondyloarthritis and psoriatic arthritis across Germany
by: Waller J, et al.
Published: (2017-03-01)

Analysis and evaluation of the cost of the treatment anti-TNFα in rheumatoid arthritis and ankylosing spondylitis. Individualised front marketed dose
by: Félix Gómez-De Rueda, et al.
Published: (2017-06-01)

Azilsartan improves the effects of etanercept in patients with active rheumatoid arthritis: a pilot study
by: Mahmood NMA, et al.
Published: (2018-08-01)

Radiographic progression based on baseline characteristics from TNF inhibitor biosimilar studies in patients with rheumatoid arthritis
by: Josef S. Smolen, et al.
Published: (2020-08-01)

Cost-Effectiveness Analysis of Etanercept in Combination with Methotrexate for Rheumatoid Arthritis - Markov Model Based on Data from Serbia
by: Kostic Marina
Published: (2017-12-01)